The digital therapeutics market size has grown exponentially in recent years. It will grow from $10.93 billion in 2025 to $14.02 billion in 2026 at a compound annual growth rate (CAGR) of 28.3%. The growth in the historic period can be attributed to growing smartphone penetration in healthcare, increased acceptance of digital health solutions, expansion of telemedicine services, early regulatory approvals for digital therapeutics, rising chronic disease burden.
The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $37.82 billion in 2030 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to increasing reimbursement support for digital therapeutics, rising demand for personalized digital care, expansion of ai-driven treatment platforms, growing partnerships between healthcare providers and tech firms, increasing focus on preventive digital health. Major trends in the forecast period include increasing adoption of software-based therapeutic solutions, rising integration of wearable health devices, growing use of remote patient monitoring platforms, expansion of evidence-based digital care programs, enhanced focus on personalized treatment pathways.
The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.
Major companies operating in the digital therapeutics market are concentrating on technological advancements such as prescription-only digital behavioral therapy platforms to expand treatment access, strengthen patient engagement, and deliver clinically validated outcomes. A prescription-only digital behavioral therapy platform employs software-based interventions delivered through smartphones or tablets, incorporating evidence-based components such as cognitive behavioral therapy (CBT), remote monitoring, and interactive goal tracking, enabling scalable, drug-free disease management and personalized patient support. For example, in July 2023, Better Therapeutics, a U.S.-based prescription digital therapeutics company, introduced AspyreRx (formerly BT 001), a digital therapeutic designed for type 2 diabetes. The solution offers a 90-day self-guided program via a smartphone application, including weekly CBT sessions, individualized goal setting, and monitoring of blood glucose and lifestyle metrics, with clinical studies showing sustained reductions in HbA1c, weight improvements, and enhanced quality-of-life outcomes.
In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.
Major companies operating in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Xealth, CogniFit Ltd.
North America was the largest region in the digital therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the digital therapeutics market by increasing costs of imported wearable components, biosensors, electronic modules, and supporting hardware devices. Healthcare providers and technology firms in North America and Europe are most affected due to dependence on imported electronics, while Asia-Pacific faces cost pressure on device manufacturing. These tariffs are increasing development and deployment costs. However, they are also encouraging local device assembly, regional software innovation, and greater emphasis on scalable software-centric therapeutic solutions.
The digital therapeutics market research report is one of a series of new reports that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.
The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.
The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $37.82 billion in 2030 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to increasing reimbursement support for digital therapeutics, rising demand for personalized digital care, expansion of ai-driven treatment platforms, growing partnerships between healthcare providers and tech firms, increasing focus on preventive digital health. Major trends in the forecast period include increasing adoption of software-based therapeutic solutions, rising integration of wearable health devices, growing use of remote patient monitoring platforms, expansion of evidence-based digital care programs, enhanced focus on personalized treatment pathways.
The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.
Major companies operating in the digital therapeutics market are concentrating on technological advancements such as prescription-only digital behavioral therapy platforms to expand treatment access, strengthen patient engagement, and deliver clinically validated outcomes. A prescription-only digital behavioral therapy platform employs software-based interventions delivered through smartphones or tablets, incorporating evidence-based components such as cognitive behavioral therapy (CBT), remote monitoring, and interactive goal tracking, enabling scalable, drug-free disease management and personalized patient support. For example, in July 2023, Better Therapeutics, a U.S.-based prescription digital therapeutics company, introduced AspyreRx (formerly BT 001), a digital therapeutic designed for type 2 diabetes. The solution offers a 90-day self-guided program via a smartphone application, including weekly CBT sessions, individualized goal setting, and monitoring of blood glucose and lifestyle metrics, with clinical studies showing sustained reductions in HbA1c, weight improvements, and enhanced quality-of-life outcomes.
In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.
Major companies operating in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Xealth, CogniFit Ltd.
North America was the largest region in the digital therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the digital therapeutics market by increasing costs of imported wearable components, biosensors, electronic modules, and supporting hardware devices. Healthcare providers and technology firms in North America and Europe are most affected due to dependence on imported electronics, while Asia-Pacific faces cost pressure on device manufacturing. These tariffs are increasing development and deployment costs. However, they are also encouraging local device assembly, regional software innovation, and greater emphasis on scalable software-centric therapeutic solutions.
The digital therapeutics market research report is one of a series of new reports that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.
The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.
The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Digital Therapeutics Market Characteristics
3. Digital Therapeutics Market Supply Chain Analysis
4. Global Digital Therapeutics Market Trends and Strategies
5. Digital Therapeutics Market Analysis of End Use Industries
7. Global Digital Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Digital Therapeutics Total Addressable Market (TAM) Analysis for the Market
9. Digital Therapeutics Market Segmentation
10. Digital Therapeutics Market Regional and Country Analysis
11. Asia-Pacific Digital Therapeutics Market
12. China Digital Therapeutics Market
13. India Digital Therapeutics Market
14. Japan Digital Therapeutics Market
15. Australia Digital Therapeutics Market
16. Indonesia Digital Therapeutics Market
17. South Korea Digital Therapeutics Market
18. Taiwan Digital Therapeutics Market
19. South East Asia Digital Therapeutics Market
20. Western Europe Digital Therapeutics Market
21. UK Digital Therapeutics Market
22. Germany Digital Therapeutics Market
23. France Digital Therapeutics Market
24. Italy Digital Therapeutics Market
25. Spain Digital Therapeutics Market
26. Eastern Europe Digital Therapeutics Market
27. Russia Digital Therapeutics Market
28. North America Digital Therapeutics Market
29. USA Digital Therapeutics Market
30. Canada Digital Therapeutics Market
31. South America Digital Therapeutics Market
32. Brazil Digital Therapeutics Market
33. Middle East Digital Therapeutics Market
34. Africa Digital Therapeutics Market
36. Digital Therapeutics Market Competitive Landscape and Company Profiles
37. Digital Therapeutics Market Other Major and Innovative Companies
40. Digital Therapeutics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Digital Therapeutics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for digital therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Software; Devices2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
3) By Application: Preventive Applications; Treatment Or Care-Related Applications
Subsegments:
1) By Software: Mobile Applications; Web-Based Platforms; Digital Therapeutics Software2) By Devices: Wearable Devices; Biosensors; Digital Therapeutic Devices
Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Propeller Health; Pear Therapeutics; Canary Health Inc.; Noom Health Inc.; Akili Interactive Labs; Better Therapeutics; Happify Health; Kaia Health; Medtronic plc; Teladoc Health Inc.; Fitbit Health Solutions; EMulate Therapeutics; BigHealth; DarioHealth; IQVIA; JOGO Health; SilverCloud Health; Biofourmis Inc.; Prosoma; Virta Health Corp.; One Drop Inc.; Lark Health; Xealth; CogniFit Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Digital Therapeutics market report include:- Omada Health Inc.
- WellDoc Inc.
- 2Morrow Inc.
- Propeller Health
- Pear Therapeutics
- Canary Health Inc.
- Noom Health Inc.
- Akili Interactive Labs
- Better Therapeutics
- Happify Health
- Kaia Health
- Medtronic plc
- Teladoc Health Inc.
- Fitbit Health Solutions
- EMulate Therapeutics
- BigHealth
- DarioHealth
- IQVIA
- JOGO Health
- SilverCloud Health
- Biofourmis Inc.
- Prosoma
- Virta Health Corp.
- One Drop Inc.
- Lark Health
- Xealth
- CogniFit Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.02 Billion |
| Forecasted Market Value ( USD | $ 37.82 Billion |
| Compound Annual Growth Rate | 28.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
